ALEMANNI, MATTEO
ALEMANNI, MATTEO
DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE (attivo dal 01/01/1998 al 30/09/2012)
Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension
2014 Rocchetti, M; Sala, L; Rizzetto, R; Staszewsky, L; Alemanni, M; Zambelli, V; Russo, I; Barile, L; Cornaghi, L; Altomare, C; Ronchi, C; Mostacciuolo, G; Lucchetti, J; Gobbi, M; Latini, R; Zaza, A
Prevention of myocardial remodeling by chronic INaL blockade in pulmonary hypertension
2012 Rocchetti, M; Rizzetto, R; Alemanni, M; Sala, L; Barile, L; Zambelli, V; Maggioni, S; Staszewsky, L; Mostacciuolo, G; Latini, R; Zaza, A
Role and mechanism of subcellular Ca2+ distribution in the action of two inotropic agents with different toxicity
2011 Alemanni, M; Rocchetti, M; Re, D; Zaza, A
Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials
2010 Macías, A; Moreno, C; Moral Sanz, J; Cogolludo, A; David, M; Alemanni, M; Pérez Vizcaíno, F; Zaza, A; Valenzuela, C; González, T
The modulation of SERCA pump activity as a tool for management of hearth failure
2009 Alemanni, M
Modulation of sarcoplasmic reticulum function by istaroxime (PST2744) in a pressure-overload heart failure model
2008 Rocchetti, M; Alemanni, M; Mostacciuolo, G; Barassi, P; Altomare, C; Chisci, R; Micheletti, R; Ferrari, P; Zaza, A